Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CGM-guided rapid titration versus standard care in young adults with newly diagnosed type 2 diabetes
ACTRN12617000480381Phase 4Completed
- Sponsor
- Royal Prince Alfred Hospital
- Start
- Jul 2017
- Modality
- Peptides, Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of metformin, empagliflozin, liraglutide and human insulin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Royal Prince Alfred Hospital. Primary endpoint: Glycaemic control assessed by HbA1c. Started Jul 2017; status: completed.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ACTRN12617000480381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12617000480381.